Cargando…
A systematic approach for introduction of novel treatments to a chronic patient group: sacubitril-valsartan as a case study
PURPOSE: To develop a model for systematic introduction and to test the feasibility in a chronic disease population. We also investigated how the approach was received by the patients. METHODS AND RESULTS: The systematic introduction approach is a seven-step procedure: step 1, define a few main crit...
Autores principales: | Norberg, Helena, Bergdahl, Ellinor, Ängerud, Karin Hellström, Lindmark, Krister |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782406/ https://www.ncbi.nlm.nih.gov/pubmed/32820363 http://dx.doi.org/10.1007/s00228-020-02979-w |
Ejemplares similares
-
Eligibility of sacubitril–valsartan in a real‐world heart failure population: a community‐based single‐centre study
por: Norberg, Helena, et al.
Publicado: (2018) -
Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors
por: Norberg, Helena, et al.
Publicado: (2019) -
Health‐related quality of life in patients with heart failure eligible for treatment with sacubitril–valsartan
por: Holmlund, Lena, et al.
Publicado: (2019) -
Self-reported medication adherence and pharmacy refill adherence among persons with ischemic stroke: a cross-sectional study
por: Norberg, Helena, et al.
Publicado: (2022) -
Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden
por: Frisk, P., et al.
Publicado: (2018)